We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Implantable Devices May Fail During Cancer Radiotherapy

By HospiMedica International staff writers
Posted on 12 Jul 2015
Patients with cardiac implantable electronic devices (CIEDs) may be at increased risk of device malfunction when undergoing radiotherapy (RT) for cancer, according to a new study. More...


Researchers at the University of Texas MD Anderson Cancer Center (Houston, USA) conducted a retrospective analysis of all patients with a functioning CIED who underwent RT between August 2005 and January 2014. They identified 249 courses of RT in 215 patients (57% with pacemakers and 43% with implantable cardioverter defibrillators (ICDs)). The main outcomes and measures were CIED malfunction, characterized as single-event upsets—data loss, parameter resets, unrecoverable resets—and delayed effects, including signal interference, pacing threshold changes, and premature battery depletion.

The results showed that malfunction of CIED attributable to RT occurred during 18 courses (7%), with 15 CIEDs experiencing single-event upsets, and three transient signal interference cases, for a total device compromise rate of 21%. All single-event upsets occurred during neutron-producing RT; no single-event upsets were found among 178 courses of non-neutron-producing RT. Patients treated to the abdomen and pelvis region were more likely to undergo a single-event upset. No delayed malfunctions were directly attributed to RT. The study was published online on June 25, 2015, in JAMA Oncology.

“In the absence of clinical benefit for higher-energy RT, the use of non-neutron-producing RT is recommended to avoid single-event upsets,” concluded lead author Jonathan Grant, MD, and colleagues of the department of radiation oncology. “If higher RT energies provide clinical benefit, however, the error rates and outcomes that we report will aid clinicians in weighing the risks of using neutron-producing RT.”

“Basically, these events represent device compromise due to a change in the memory state of the circuitry,” said Charles Thomas, Jr. MD, PhD, professor and chairman of the department of radiation medicine at Oregon Health and Science University (Portland, OR, USA), in an accompanying editorial. “There exists an opportunity to design trials that incorporate next-generation and commercially available electronic monitoring devices in this patient population to detect more subtle dysrhythmias, device sensor adjustments, and/or transient threshold alterations.”

Single-event upsets in CIEDs caused by high-energy radiation result when high-energy photons (over 10 MV) interact with materials in a linear accelerator, causing high-energy neutrons to be emitted throughout the treatment room. The neutrons interact thermally with boron atoms found in the metal oxide semiconductor components contained in contemporary CIEDs, causing disruptions in the electric currents.

Related Links:

University of Texas MD Anderson Cancer Center



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.